Dabigatran Etexilate (BIBR-1048) is the prodrug of dabigatran used as an thrombin inhibitor to treat blood clot.

Heparin sodium (150,160,170,180unit/mg), a sulfated polysaccharide belonging to the family of glycosaminoglycans, has numerous important biological activities associated with its interaction with diverse proteins.

Dabigatran Etexilate mesylate (BIBR-1048; BIBR 1048MS) is the prodrug of dabigatran which is a potent and nonpeptidic small molecule anti-thrombotic agent that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule.

Argatroban (MD-805; MCI-9038; Argipidine) is a potent and selective synthetic thrombin inhibitor with Ki ranging from 5 nM to 39 nM.

Argatroban hydrate (also known as MD-805; MCI-9038; Argipidine) is a potent and selective synthetic thrombin inhibitor with Ki ranging from 5 nM to 39 nM.

Dabigatran (formerly BIBR 953; Pradaxa; Prazaxa; BIBR 953ZW) is a potent, nonpeptide, reversible, selective and direct thrombin inhibitor used to treat blood clots.

Warfarin (WARF42; Athrombine-K; Coumadin) is a medication that is used as an anticoagulant in the prevention of thrombosis and thromboembolism, the formation of blood clots in the blood vessels and their migration elsewhere in the body, respectively.

Magnoflorine is a novel and potent alkaloid.

Heparin sodium salt (MW 15kDa), a polymerized Heparin with a molecular weight of 15kDa, is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa.

Dabigatran ethyl ester HCl is the hydrochloride salt of Dabigatran ethyl ester which is the ethyl ester form of dabigatran.